MENU
XERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xeris Biopharma Holdings (XERS) Ownership - Who owns Xeris Biopharma Holdings?
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
877.65M
P/E Ratio
N/A
Total Cash
58.44M
Projected Growth
N/A
Total Debt
268.75M
Revenue
222.55M
Risk (Beta)
0.37
Dividend Yield
N/A
Total Cash/Share
0.36
Total Debt/Equity
N/A
Revenue/Share
1.49 USD as % of share price
Fundamentals
XERS
Capitalization
878M
P/E Ratio
N/A
Risk (Beta)
0.37
Dividend Yield
N/A
Total Cash
58.4M
Total Cash/Share
0.36
Total Debt
269M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.49%
Revenue
223M
ROE
N/A
Book Value
-35.13M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
1.72
Current Revenue Per Employee
152586.30
Dividends Per Share - Security
N/A
EBITDA
-4.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.48
Revenue To Assets
-13.83
Shares Held By Institutions
614M
Shares Outstanding - Current
160M
Total Liabilities
351M
Total Volume MTD
N/A
Value
-1
Gain YTD
61.652
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of ready-to-use, liquid-stable injectables
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1375 West Fulton Street
Phone
+1 844 445-5704
Employees
377
Web
https://www.xerispharma.com